Development of a human iPSC and patient phenotyping resource for preclinical investigations of neurodevelopmental disorders
Authors:
Open Access
- 6 August 2026
- journal article
- Published by Elsevier in Stem Cell Research
- Vol. 95, 104073
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health and Neurosciences
- U.S. Department of War
- National Institute of Neurological Disorders and Stroke
- PTEN Research (BCH-20-001)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Boston Children's Hospital
This publication has 37 references indexed in Scilit:
- Neuronal hyperactivity becomes mTORC1 independent due to transcriptional changes in tuberous sclerosis complex disease modelsCell Reports, 2025
- Increased degradation of FMRP contributes to neuronal hyperexcitability in tuberous sclerosis complexCell Reports, 2023
- Enhanced prime editing systems by manipulating cellular determinants of editing outcomesCell, 2021
- Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 Deficiency Disorder (CDD)Stem Cell Research, 2021
- Best Practices for Translational Disease Modeling Using Human iPSC-Derived NeuronsNeuron, 2018
- Improving single-cell cloning workflow for gene editing in human pluripotent stem cellsStem Cell Research, 2018
- Disentangling intolerance of uncertainty and threat appraisal in everyday situationsJournal of Anxiety Disorders, 2018
- Behavior and Sensory Interests Questionnaire: Validation in a sample of children with autism spectrum disorder and other developmental disabilityResearch in Developmental Disabilities, 2016
- Investigating the Measurement Properties of the Social Responsiveness Scale in Preschool Children with Autism Spectrum DisordersJournal of Autism and Developmental Disorders, 2012
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007